Sangamo Therapeutics (SGMO) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.14
-0.08
-0.02
0.04

Details

Expected EPS
-0.010067
Actual EPS
-0.08
Surprise EPS
-0.07
Surprise Percent
+694.68%

Description

Sangamo Therapeutics (SGMO) has reported earnings of -0.08 per share for Q3 2025.

0 Comments

Share your thoughts